ShockWave’s disruptive approach within the calcified cardiovascular disease space creates a first-mover advantage offering the opportunity of robust sales growth. ShockWave Medical’s business model ...
SANTA CLARA, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc., a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified ...
People walk into physiotherapy clinics with all kinds of expectations. Some have been managing discomfort for months. Others want to return to a spot they love. Another group may simply ...
Shockwave Medical specializes in developing and commercializing medical devices using IVL technology for treating calcified plaque in vascular and heart valve diseases. The company has achieved ...
FREDERICK, MD, UNITED STATES, February 3, 2026 /EINPresswire.com/ — Limitless Evolution announces the launch of the ReGen Medical RCT Shockwave Device, an advanced ...
In a deal that might as well be termed a heart-to-heart, Shockwave Medical has made a bid to combine Neovasc’s cardiac device business with its own. Shockwave has offered up $27.25 in upfront cash for ...
As an adjunct to bypass surgery for ischemic cardiomyopathy, a cardiac shockwave therapy aimed at regenerating ischemic myocardium boosted left ventricular ejection fraction (LVEF) and physical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results